Related Experiment Video
Updated: Jul 30, 2025

07:39
SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
Published on: June 28, 2019
24.1K
Recent Advances in Senolysis for Age-Related Diseases
Sae Aratani1,2, Makoto Nakanishi1
1Division of Cancer Cell Biology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
Physiology (Bethesda, Md.)
|May 16, 2023
Summary
Cellular senescence, a key factor in aging, can be targeted by senolysis, a strategy that eliminates aging cells. This review explores the benefits of senolytic drugs for managing aging and related diseases.
Area of Science:
- Gerontology and cellular biology, focusing on the mechanisms of aging and age-related diseases.
Background:
- Cellular senescence is a fundamental biological process implicated in aging and the development of various geriatric conditions.
- Senescent cells accumulate with age and contribute to tissue dysfunction and disease pathogenesis.
Purpose of the Study:
- To review the therapeutic potential of senolysis, a strategy aimed at selectively eliminating senescent cells.
- To highlight the benefits and applications of senolytic drugs in combating aging and age-related diseases.
Main Methods:
- Literature review of existing studies on cellular senescence and senolytic therapies.
- Analysis of data from preclinical and clinical investigations of senolytic drugs.
Main Results:
- Multiple senolytic drugs have been identified and demonstrated efficacy in preclinical models.
- Senolysis has shown potential in ameliorating age-related conditions and improving healthspan.
Conclusions:
- Senolysis represents a promising therapeutic avenue for targeting aging and geriatric diseases.
- Further research and clinical translation of senolytic drugs could offer significant health benefits for the aging population.
More Related Videos
Related Concept Videos
Mitochondria
14.0K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
14.0K
Aging
92
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
92
Electron Transport Chain: Complex I and II
14.6K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
14.6K
Alzheimer's Disease: Treatment
229
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
229
Alzheimer's Disease: Overview
543
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
543

